Member Info for Basscadet

LOL. Maybe just not following the logic of having strong evidence for someting in the public domain that many people are waiting for a high impact regulated RNA on. It could well be in good faith. I'll have to then figure out how and why more didn't buy in to take the SP up several pounds. A point I agree with all the rampers is possible if DDDD reports a successfull phase 2 trial for an IBS treatment. Because then there will surely be a profitable angle to find during similar scenarios.

This has got to be dodgy sufely. Otherwise the share price would be much higher than it is and there would be analysts everywhere harrassing people on medical trials like papperazi.

I'll go mid November Sjm321. Biden wins, Trump acts like a tinpot dictator and tries to start a civil war. $2100 could be cheap.

Definitely definitely definitely seen it over 17.5p this time.

I saw it! It went above 17.5p.

NANO's tech was farmed out to one of the big agri companies wasn't it ddubya who were running a trial and then never heard from again? So, either it didn't have a beneficial enough effect or they couldn't scale up for the right cost. Maybe NANO stopped supporting it during the pivot to Apple. Would be interesting to get an update from the company. Would also be interested in a medical update. Last I heard about that was that commericialisation was being considered with an expert business development group from a consortium of US universities and then also never heard about again.

Sorry, provision is £1.8M not $18M.

I'm with you on the opacity of reporting Qd22 although I doubt anyone could accurately state the financial performance of a business as complicated as IQE in a few paragraphs and do it with clarity. I would guess it's something to do with minimising tax so not a bad thing for investors but who can tell for sure.

The only detail I would add to your summary is where the write off came from. Seems there was a minimum royalty clause in the contract, "The onerous contract provision represents the cost of minimum future royalty payments payable to Translucent Inc. in the period prior to the expected commercial exploitation of the Group’s filter technology." It says the provision is £18M which doesn't match any of the headline figures in the report, lol! Maybe they have accepted the write off for multiple years in this report to keep it clear going forward.

Gotrader, I'm sure the new iPhone will arrive on time but will Trump get it banned in China ruining their plans and supply chains!?

I understand that wondergoals but it is at least a very low number. IQE pretty much always has a stronger H2. They are guiding here at least better than a 23% worse H2. I don't necessrily think this is a bad thing but it means the SP will tread water here intil the next trading update when we find out what at least ireally means.

A poster on ADVFN came up with the plausible explanation that they were guiding down 20% due to COVID risk. The wording around that risk has plenty of ambiguity. Do they know demand is dropping off or is it expected drop off if COVID affects their markets negatively?

Encouraed that major customers' results and guidance has recently been very bullish, that IQE say the first 2 months of H2 were strong and that the CEO says we are at the start of a non-linear curve. That's pretty strong guidance albeit in controvension of the actual guidance. I think we'll get another set of bullish customer results proir to IQE's December update which will guide much higher than 165M. In the meantime we've probably got a buying opportunity.

Also says, "At least a mid-single digit adjusted operating profit for FY20." They already have £4.3M. Does that mean no profit in the second half? If it's a case of under promising they may be in danger of muddying the message a bit here.

89.9M a great number. Happy with the operating profit and debt reduction. Nice to see strong growth in all areas. Hesitant to call it a blow out half though as full year guidance is only "At least 165M." That seems very low. Is it a case of new the new CFO and chairman wanting to under promise and over deliver?

$550k a quarter is a lot of pods. Assuming the order repeats, $2.2m revenue should represent a much bigger market cap. It be recognised sooner of later.

Looks like Kraft Heinz are way ahead of BIOM on the technology though if their pods compost in a normal environment and don't need industrial composters.

IQE doesn't make many if any components for silicon chips so there should be no direct impact. I do find the US justification laughable. They make components for the military. Are we supposed to shut down Boeing then, BAE Systems, lol

Don't have any details hamsters. Just read someone mention it on another board sometime. I wouldn't take it particularly seriously.

The company has stated they want to be on tha NASDAQ and now they are having the success to make it happen. I think there's a closed news period after listing though so suspect they will wait until this current run of trial results is over and then do it. Not sure why they would have to leave AIM and not have a dual listing?

I'm sure it's a common scenario yes ddubya. It's very unlikely that it wouldn't be covered. Just thinking out loud.

No Nige. I asked if the contract with NANO's TPF partners would cover the counter claim.

Will the coimpany's agreement with Mintz and the financiers cover the counterclaim. If not and Nanoco have to fund the defence themselves is this just a tactic to drain company of what little money it has in order to pressure it into accepting a smaller settlement?

All still very much smells of a settlement.

17.5p is a tough nut to crack.